REGISTERED NUMBER: |
Abridged Unaudited Financial Statements |
for the Year Ended 30th April 2023 |
for |
Pivotal 4Pharma Limited |
REGISTERED NUMBER: |
Abridged Unaudited Financial Statements |
for the Year Ended 30th April 2023 |
for |
Pivotal 4Pharma Limited |
Pivotal 4Pharma Limited (Registered number: 06881976) |
Contents of the Financial Statements |
for the Year Ended 30th April 2023 |
Page |
Company Information | 1 |
Abridged Statement of Financial Position | 2 |
Notes to the Financial Statements | 3 |
Pivotal 4Pharma Limited |
Company Information |
for the Year Ended 30th April 2023 |
DIRECTORS: |
SECRETARY: |
REGISTERED OFFICE: |
REGISTERED NUMBER: |
ACCOUNTANTS: |
Bank House |
Market Square |
Congleton |
Cheshire |
CW12 1ET |
Pivotal 4Pharma Limited (Registered number: 06881976) |
Abridged Statement of Financial Position |
30th April 2023 |
30/4/23 | 30/4/22 |
Notes | £ | £ | £ | £ |
FIXED ASSETS |
Tangible assets | 4 |
CURRENT ASSETS |
Debtors |
Cash at bank |
CREDITORS |
Amounts falling due within one year |
NET CURRENT ASSETS |
TOTAL ASSETS LESS CURRENT LIABILITIES |
CAPITAL AND RESERVES |
Called up share capital | 5 |
Retained earnings |
SHAREHOLDERS' FUNDS |
The directors acknowledge their responsibilities for: |
(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered. |
The financial statements were approved by the Board of Directors and authorised for issue on |
Pivotal 4Pharma Limited (Registered number: 06881976) |
Notes to the Financial Statements |
for the Year Ended 30th April 2023 |
1. | STATUTORY INFORMATION |
Pivotal 4Pharma Limited is a |
2. | ACCOUNTING POLICIES |
Basis of preparing the financial statements |
Going Concern |
The directors have considered the potential impact of COVID-19 on the principal activities of the business and they believe that they have sufficient resources in place to operate for the foreseeable future. Thus, they continue to adopt the going concern basis of accounting in preparing the financial statements |
Turnover |
Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for services rendered, stated net of discounts and of Value Added Tax. |
Income is recognised when services have been delivered to customers |
Tangible fixed assets |
Fixtures and fittings | - |
Computer equipment | - |
Tangible fixed assets are stated at cost less accumulated depreciation and accumulated impairment losses. |
Financial instruments |
The following assets and liabilities are classified as financial instruments - trade debtors, trade creditors and directors loans. |
Directors loans (being repayable on demand), trade debtors and trade creditors are measured at the undiscounted amount of the cash or other consideration expected to be paid or received. |
Financial assets that are measured at amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence is found, an impairment loss is recognised in the statement of income and Retained Earnings. |
3. | EMPLOYEES AND DIRECTORS |
The average number of employees during the year was |
Pivotal 4Pharma Limited (Registered number: 06881976) |
Notes to the Financial Statements - continued |
for the Year Ended 30th April 2023 |
4. | TANGIBLE FIXED ASSETS |
Totals |
£ |
COST |
At 1st May 2022 |
Disposals | ( |
) |
At 30th April 2023 |
DEPRECIATION |
At 1st May 2022 |
Eliminated on disposal | ( |
) |
At 30th April 2023 |
NET BOOK VALUE |
At 30th April 2023 |
At 30th April 2022 |
5. | CALLED UP SHARE CAPITAL |
Allotted, issued and fully paid: |
Number: | Class: | Nominal | 30/4/23 | 30/4/22 |
value: | £ | £ |
Ordinary | £1 | 2 | 2 |
Ordinary A | £1 | 1 | 1 |
Ordinary B | £1 | 1 | 1 |
4 | 4 |
6. | ULTIMATE CONTROLLING PARTY |
Mr T and Mrs R Sheldon, the directors control the company by virtue of holding 100% of the issued ordinary share capital. |